We are live on ! Find out more
TRVI icon

Trevi Therapeutics
TRVI

18 hedge funds and large institutions have $31.7M invested in Trevi Therapeutics in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

1.95% less ownership

Funds ownership: 72.72% → 70.77% (-1.9%)

41% less capital invested

Capital invested by funds: $53.5M → $31.7M (-$21.7M)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$83.2K
2
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$48.6K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$48K
4
WA
WealthTrust Axiom
Pennsylvania
+$37.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$12.4K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$700K
2
OFM
Omega Fund Management
Massachusetts
-$364K
3
Bank of America
Bank of America
North Carolina
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$14.4M – – –
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$11.7M – – –
OFM
3
Omega Fund Management
Massachusetts
$3.33M -$364K -112,499 -8%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.4M -$700K -216,200 -27%
Vanguard Group
5
Vanguard Group
Pennsylvania
$322K – – –
BCM
6
Bridgeway Capital Management
Texas
$242K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$118K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$62K +$83.2K +25,700 New
BlackRock
9
BlackRock
New York
$56K +$2.98K +919 +4%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$36K +$48K +14,828 New
Canada Pension Plan Investment Board
11
Canada Pension Plan Investment Board
Ontario, Canada
$36K +$48.6K +15,000 New
Northern Trust
12
Northern Trust
Illinois
$28K – – –
WA
13
WealthTrust Axiom
Pennsylvania
$27K +$37.2K +11,500 New
LPL Financial
14
LPL Financial
California
$24K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$13K +$12.4K +3,821 +272%
First Manhattan
16
First Manhattan
New York
$4K +$3.24K +1,000 +100%
Osaic Holdings
17
Osaic Holdings
Arizona
$2K – – –
Bank of America
18
Bank of America
North Carolina
– -$1K -179 Closed

TRVI Hedge Fund Activity: Q4 2020 in Review

18 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Trevi Therapeutics (TRVI) for Q4 2020, worth a combined $31.7M — down 41% from $53.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TRVI positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $83.2K. The largest seller was Fidelity Investments, cutting an estimated $700K.

  • 18 institutional investors held Trevi Therapeutics (TRVI) as of Q4 2020, up from 16 in Q3 2020.
  • Funds reported $31.7M of Trevi Therapeutics stock for Q4 2020, down 41% quarter-over-quarter.
  • 4 funds opened new Trevi Therapeutics positions in Q4 2020 and 2 closed out, a net change of +2 holders.
  • The largest Trevi Therapeutics buyer in Q4 2020 was Renaissance Technologies, an estimated $83.2K added.
  • The largest Trevi Therapeutics seller in Q4 2020 was Fidelity Investments, an estimated $700K sold.

Based on aggregated 13F filings for Q4 2020.